Article Information
History
- March 27, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Diana Karamacoska1,
- Daniel K.Y. Chan1,2,
- Isabella Leung1,
- Jian-xun Liu3,
- Henry Brodaty4,
- Paul P Fahey5,
- Alan Bensoussan1 and
- Dennis H. Chang1,*
- 1NICM Health Research Institute, Western Sydney University, Penrith, NSW 2751, Australia
- 2South Western Sydney Clinical School, University of New South Wales, Kensington, NSW 2052, Australia
- 3Research Center, Xiyuan Hospital, China Academy of Traditional Chinese Medicine, Beijing 100091, China
- 4Centre for Healthy Brain Ageing, School of Psychiatry, University of New South Wales, Kensington, NSW 2052, Australia
- 5School of Health Sciences, Western Sydney University, Penrith, NSW 2751, Australia
- ↵*Corresponding author Email: d.chang{at}westernsydney.edu.au
Posted March 27, 2022.
Study Protocol for a Phase III Randomised Controlled Trial of Sailuotong (SLT) for Vascular Dementia and Alzheimer’s Disease with Cerebrovascular Disease
